These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7517832)

  • 1. Hormone replacement therapy and the cardiovascular system. Nonlipid effects.
    Stevenson JC; Crook D; Godsland IF; Collins P; Whitehead MI
    Drugs; 1994; 47 Suppl 2():35-41. PubMed ID: 7517832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic and cardiovascular consequences of HRT.
    Stevenson JC
    Br J Clin Pract; 1995; 49(2):87-90. PubMed ID: 7779651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of the menopause and oestrogen replacement.
    Stevenson JC
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):449-67. PubMed ID: 8931905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms whereby oestrogens influence arterial health.
    Stevenson JC
    Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):39-42. PubMed ID: 8706955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HRT mechanisms of action: carbohydrates.
    Stevenson JC; Proudler AJ; Walton C; Godsland IF
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 1():50-5. PubMed ID: 8199641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Menopause and hormone replacement therapy (HRT) in women with diabetes].
    Cyganek K
    Przegl Lek; 1999; 56(5):362-71. PubMed ID: 10554574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy: cardiovascular benefits for aging women.
    Sites CK
    Coron Artery Dis; 1998; 9(12):789-93. PubMed ID: 9894922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study.
    Fineberg SE
    Drugs Aging; 2000 Dec; 17(6):453-61. PubMed ID: 11200306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various actions of oestrogens on the vascular system.
    Stevenson JC
    Maturitas; 1998 Sep; 30(1):5-9. PubMed ID: 9819777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study.
    McPherson R
    Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
    Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
    J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone replacement therapy on coagulation, fibrinolysis, and thrombosis risk in postmenopausal women.
    Koh KK; Horne MK; Cannon RO
    Thromb Haemost; 1999 Aug; 82(2):626-33. PubMed ID: 10605760
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution.
    Gower BA; Nagy TR; Goran MI; Smith A; Kent E
    J Clin Endocrinol Metab; 2000 May; 85(5):1770-5. PubMed ID: 10843150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the cardiovascular impact of hormonal replacement therapy in menopausal women].
    Gaspard UJ
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):671-6. PubMed ID: 8991899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.